PROGENTOS THERAPEUTICS
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
PROGENTOS THERAPEUTICS
Industry:
Life Science Medical Therapeutics
Founded:
2023-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.progentos.com
Status:
Active
Total Funding:
65 M USD
Technology used in webpage:
CrUX Dataset CrUX Top 50m
Current Advisors List
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Progentos Therapeutics
Longwood Fund
Longwood Fund investment in Series A - Progentos Therapeutics
Dolby Family Ventures
Dolby Family Ventures investment in Series A - Progentos Therapeutics
Alta Partners
Alta Partners investment in Series A - Progentos Therapeutics
Mission BioCapital
Mission BioCapital investment in Series A - Progentos Therapeutics
Official Site Inspections
http://www.progentos.com Semrush global rank: 14.3 M Semrush visits lastest month: 88
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Progentos Therapeutics"
Progentos Therapeutics - Crunchbase Company Profile & Funding
Regenerative Medicine for Multiple Sclerosis: A therapeutic approach aimed at regenerating myelin by activating oligodendrocyte progenitor cells to form new oligodendrocytes, potentially …See details»
Progentos Therapeutics - PitchBook
Progentos Therapeutics General Information Description. Developer of medicines designed to treat chronic diseases. The company is generating novel small-molecule therapeutics that are …See details»
Chris Loose - Progentos
Chris Loose, PhD, is Co-Founder and Chief Executive Officer of Progentos Therapeutics. Previously, Chris served as Frequency Therapeutics’ Chief Scientific Officer since co-founding …See details»
Progentos Therapeutics - Contacts, Employees, Board Members, …
Organization. Progentos Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 3. Number of Board Member and …See details»
Progentos Therapeutics - VentureRadar
"Progentos Therapeutics is a company focused on developing regenerative medicine for the treatment of multiple sclerosis (MS). Their innovative approach involves creating small …See details»
Progentos - Company Profile - Tracxn
Nov 19, 2024 Progentos ranks 92nd among 425 active competitors. 150 of its competitors are funded while 74 have exited. Overall, Progentos and its competitors have raised over $10.6B …See details»
About - ProGentus
What is ProGentus? We are a subsidiary of Trans Ova Genetics, which means we are supported by the most experienced and knowledgeable professionals in the genetics and embryo …See details»
Progentus - Company Profile & Staff Directory - ContactOut
Progentus is an IT services company that offers Value Added Resellers, System Integrators and Solution Providers Technical and Financial analysis capabilities that can be resold to their …See details»
Progentos Therapeutics - Tech Company Profile - Gaebler.com …
May 20, 2024 Funded Tech Companies Progentos Therapeutics. Progentos Therapeutics is a healthcare services company, located in Watertown. Venture capital investment was provided …See details»
Progentos Therapeutics Closes $65 Million Series A Financing to …
May 20, 2024 Founded by Chief Executive Officer Chris Loose, Ph.D. and Chief Scientific Officer, Sanjay Magavi, Ph.D., Progentos to Drive Clinical Development of Novel Therapeutics …See details»
ProGentus - Overview, News & Similar companies | ZoomInfo.com
ProGentus Corp is a company that operates in the Farming industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquartered in Sioux Center, Iowa. Read more. …See details»
ProGentus THE FULL GENETIC EQUATION WTrans Ova Genetics, …
ProGentus.com www.ProGentus.com Embryo and Semen Products to Improve Profit SOLUTIONS WHO WE ARE W e are a subsidiary of Trans Ova Genetics, which means we …See details»
What is ProGentus? We are... - ProGentus - Genetic Solutions
Jun 7, 2018 What is ProGentus? We are powered by Trans Ova Genetics technology, which means we are supported by the most experienced and knowledgeable professionals in the …See details»
Progentos Therapeutics Closes $65 Million Series A ... - Business …
May 20, 2024 Founded by Chief Executive Officer Chris Loose, Ph.D. and Chief Scientific Officer, Sanjay Magavi, Ph.D., Progentos to Drive Clinical Development of Novel Therapeutics …See details»
Progentos receives $65M to develop myelin regeneration therapies
May 24, 2024 Progentos secured $65 million to support the clinical development of medications to promote myelin regeneration and restore function in MS.See details»
Progentos emerges with $65M for multiple sclerosis trials with
May 20, 2024 A new biotech emerged to take forward the lead preclinical work developed by Frequency Therapeutics, a regenerative medicines company that gave up its Nasdaq spot in a …See details»
ProGentus - Genetic Solutions - Facebook
ProGentus - Genetic Solutions. 3,321 likes. ProGentus, a division of Trans Ova Genetics, strives to grow genetic programs by providing dairy and beef genetic products and services with the …See details»
Products - ProGentus
ProGentus Products give Producers the opportunity to make every generation in their herd the best generation. GENPLUS ™ EMBRYOS. GenPlus ™ Embryos allow you to harness the …See details»
Check Out These New Livestock Products for Ranchers
Nov 9, 2023 ProGentus experts select the F1 embryos from the company’s herd, predetermined to be only females. The Angus cows that produce the embryos are in the top 1% of EPD traits …See details»